Disposition kinetics of propranolol isomers in the perfused rat liver

Journal of Pharmacology and Experimental Therapeutics

Volumn 311, Issue 2, 2004, Pages 822-829

  Hung, Daniel Y ^a   Siebert, Gerhard A ^a   Chang, Ping ^a   Anissimov, Yuri G ^a   Roberts, Michael S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MONENSIN; PROPRANOLOL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG PENETRATION; ISOMER; LIVER LYSOSOME; LIVER MICROSOME; LIVER PERFUSION; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; PROTON TRANSPORT; RAT; SURFACE PROPERTY; THEORETICAL MODEL;

ANIMALS; ISOMERISM; LIVER; MALE; PERFUSION; PROPRANOLOL; RATS; RATS, WISTAR;

EID: 6244309280     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.070011     Document Type: Article

References (31)

1. Anderson JH, Anderson RC, and Iben LS (1978) Hepatic uptake of propranolol. J Pharmacol Exp Ther 206:172-180.
2. Bai SA, Wilson MJ, Walle UK, and Walle T (1983) Stereoselective increase in propranolol bioavailability during chronic dosing in the dog. J Pharmacol Exp Ther 227:360-364.
3. Barrett AM and Cullum VA (1968) Lack of inter-action between propranolol and mebanazine. J Pharm Pharmacol 20:911-915.
4. Cheung K, Hickman PE, Potter JM, Walker NI, Jericho M, Haslam R, and Roberts MS (1996) An optimized model for rat liver perfusion studies. J Surg Res 66:81-89.
5. Daniel WA (2003) Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions. Prog Neuropsychopharmacol Biol Psychiatry 27:65-73.
6. Elliott SL, Morgan DJ, Angus PW, Ghabrial H, and Smallwood RA (1993) The effect of hypoxia and acidosis on propranolol clearance in the isolated perfused rat liver preparation. Biochem Pharmacol 45:763-765.
7. Goldstein A, Aronow I, and Kalman SM (1974) Principles of drug action, in The Basis of Pharmacology, pp 227-300, John Wiley and Sons, New York.
8. Hung DY, Chang P, Cheung K, McWhinney B, Masci PP, Weiss M, and Roberts MS (2002) Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity and nature of drug. J Pharmacol Exp Ther 301:1079-1087.
9. Hung DY, Chang P, Weiss M, and Roberts MS (2001) Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process. J Pharmacol Exp Ther 297:780-789.
10. Ishida R, Suzuki K, Masubuchi Y, Narimatsu S, Fujita S, and Suzuki T (1992) Enzymatic basis for the non-linearity of hepatic elimination of propranolol in the isolated perfused rat liver. Biochem Pharmacol 44:2281-2288.
11. Kawashima K, Levy A, and Spector S (1976) Stereospecific radioimmunoassay for propranolol isomers. J Pharmacol Exp Ther 196:517-523.
12. Keiding S and Steiness E (1984) Flow dependence of propranolol elimination in perfused rat liver. J Pharmacol Exp Ther 230:474-477.
13. Lalka D, Griffith RK, and Cronenberger CL (1993) The hepatic first-pass metabolism of problematic drugs. J Clin Pharmacol 33:657-669.
14. Le Couteur DG, Rivory LP, and Pond SM (1993) Hepatic intracellular pH during the prereplicative period following partial hepatectomy. Am J Physiol 264:6767-773.
15. Ludden TM (1991) Nonlinear pharmacokinetics: clinical implications. Clin Pharmacokinet 20:429-446.
16. Marier JF, Pichette V, and du Souich P (1998) Stereoselective disposition of propranolol in rabbits: role of presystemic organs and dose. Drug Metab Dispos 26:164-169.
17. Miyauchi S, Sawada Y, Iga T, Hanano M, and Sugiyama Y (1993) Dose-dependent hepatic handling of L-propranolol determined by multiple indicator dilution method: influence of tissue binding of L-propranolol on its hepatic elimination. Biol Pharm Bull 16:1019-1024.
18. Pearson AA, Gaffney TE, Walle T, and Privitera PJ (1989) A stereoselective central hypotensive action of atenolol. J Pharmacol Exp Ther 250:759-763.
19. Rhoades R and Pflanzer R (1996) Human Physiology. Harcourt Brace College Publishers, Philadelphia.
20. Roberts MS, Donaldson JD, and Rowland M (1988) Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity and systemic recycling on hepatic elimination. J Pharmacokinet Biopharm 16:41-83.
21. Roberts MS and Rowland M (1986) Correlation between in-vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model. J Pharm Pharmacol 38:177-181.
22. Shand DG (1976) Pharmacokinetics of propranolol: a review. Postgrad Med J 52 (Suppl 4):22-25.
23. Siebert GA, Hung DY, Chang P, and Roberts MS (2004) Ion-trapping, microsomal binding and unbound drug distribution in the hepatic retention of basic drugs. J Pharmacol Exp Ther 308:228-235.
24. Smallwood RH, Mihaly GW, Smallwood RA, and Morgan DJ (1988) Propranolol elimination as described by the venous equilibrium model using flow perturbations in the isolated perfused rat liver. J Pharm Sci 77:330-333.
25. Soboll S, Elbers R, Scholz R, and Heldt HW (1980) Subcellular distribution of di- and tricarboxylates and pH gradients in perfused rat liver. Hoppe-Seyler's Z Physiol Chem 361:69-76.
26. Stoschitzky K, Egginger G, Zernig G, Klein W, and Lindner W (1993) Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic and radioligand binding studies. Chirality 5:15-19.
27. Suzuki T, Ohkuma T, and Isozaki S (1981) Nonlinear first-pass metabolism of propranolol in the rat. J Pharmacobiodyn 4:131-141.
28. von Bahr C, Hermansson J, and Lind M (1982) Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes: species differences in stereoselectivity. J Pharmacol Exp Ther 222:458-462.
29. Weiss M, Kuhlmann O, Hung DY, and Roberts MS (2000) Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver. Br J Pharmacol 130:1331-1338.
30. Weiss M and Roberts MS (1996) Tissue distribution kinetics as determinant of transit time dispersion of drugs in organs: application of a stochastic model to the rat hindlimb. J Pharmacokinet Biopharm 24:173-196.
31. Weiss M, Stedtler C, and Roberts MS (1997) On the validity of the dispersion model of hepatic drug elimination when intravascular transit time densities are long-tailed. Bull Math Biol 59:911-929.